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A 34-year-old woman tested HIV-positive in December 2005,
and was referred to a specialist HIV unit in mid-January 2006.
She had presented to her general practitioner with
oesophageal candidiasis and a history of a cough and
occasional loose stools since November 2005, with an 8 kg
weight loss over the past 6 months. She had no history of
other opportunistic infections or HIV-related conditions. On
examination her temperature was 38.5°C and she had sinus
tachycardia. Wasting, pallor and severe oral thrush were noted.
There was no lymphadenopathy, hepatomegaly or spleno-
megaly, and the findings on respiratory examination were
normal. 
The patient refused admission and results of the following
investigations were obtained as an outpatient: haemoglobin
6.9 g/dl (normocytic, normochromic), white cell count 5.56 
109/l and platelet count 88 1011/ l. The CD4 count was 27
cells/µl (4.32%) and the viral load > 750 000 copies/ml. The
serum albumin level was 22 g/l and the lactate dehydrogenase
(LDH) level 3 116 U/l; levels of alanine aminotransferase (ALT),
alkaline leucocyte phosphatase (ALP) and gamma-glutamyl
transpeptidase (GGT) were within normal limits. Aerobic,
anaerobic and mycobacterial blood cultures were negative. A
bone marrow aspirate and trephine showed disordered
erythropoiesis in keeping with retroviral disease. Histological
examination of the trephine biopsy specimen showed no
granulomas or signs of malignancy. The Coombs test was
negative and the haptoglobin level was in the normal range.
The chest radiograph was normal. The patient was given a
blood transfusion which brought the haemoglobin level to
9.2 g/dl, and was treated with fluconazole.
Antiretroviral therapy (ART) was commenced with stavudine,
lamivudine and efavirenz. Symptomatic peripheral neuropathy
was detected 2 weeks later and the stavudine was replaced
with tenofovir. Four weeks after starting ART the patient’s
condition  deteriorated and she was found to be mildly
confused, apyrexial and pale. A right-sided pleural effusion
had developed. Aspiration of the effusion returned
bloodstained fluid, cytological examination of which showed a
high-grade plasma blastic non-Hodgkin’s lymphoma. The
patient was assessed by an oncologist but refused further
treatment and subsequently died. 
COMMENT
This case study encapsulates a clinical dilemma frequently
encountered by South African HIV clinicians: a patient with
advanced HIV disease presents for the first time with
prominent constitutional symptoms; a careful evaluation for
opportunistic infections is unrevealing; and ART is
commenced. Within a few weeks of initiating ART a focal (and
in this case fatal) disease process becomes apparent.
At issue here is how far the evaluation should be taken before
ART is begun. The question becomes especially relevant in
resource-constrained environments. 
Diagnosing and treating opportunistic infections before
starting ART is essential in order to reduce the possibility of
immune reconstitution disease, and the likelihood of
significant drug interactions. 
Advanced HIV infection can cause fever and weight loss
(constitutional symptoms) without underlying opportunistic
infection. This is, however, a diagnosis of exclusion. The
evaluation is best approached by considering the patient under
the diagnostic label of fever of unknown origin (FUO). Typically,
FUO is diagnosed using Durack’s and Street’s criteria:1
temperature of 38.3°C or higher on multiple occasions over 3
days for inpatients or for more than 4 weeks for outpatients;
failure to identify infectious organisms after at least 2 days of
incubation of microbiological cultures; and a diagnosis that
remains uncertain after 3 days despite appropriate
investigation. In the South African context repeated
temperature measurements can be difficult to obtain, and a
history of fevers and chills or drenching night sweats
persisting for more than 2 - 4 weeks is highly suggestive of
FUO. Acute bacterial infections are unlikely to be confused
with FUO owing to the abrupt onset of symptoms, presence of
focal pain, and body fluids containing a predominance of
neutrophils. 
Various forms of tuberculosis are probably the most common
cause of FUO in HIV-infected adults.2 If cough is a prominent
symptom at least 2 - 3 sputum specimens should be sent for
staining for acid-fast bacilli.3,4 The yield can be improved by
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inducing sputum using an ultrasonic nebuliser and hypertonic
saline5,6 – if at all possible this specimen should be sent for
mycobacterial culture. Other appropriate initial investigations
would include a full blood count and white cell differential
count, measurement of liver enzymes and C-reactive protein,
urine analysis and a chest radiograph. Ultrasound of the
abdomen and pericardial space is a useful technique with the
potential to identify pericardial effusions, intra-abdominal
lymph nodes, hepatic and splenic lesions, ascites and pelvic
masses. The aim of the initial set of investigations is to detect
a focal process that could potentially be the site of an
opportunistic infection. Tuberculosis is compatible with
pulmonary infiltrates (including micronodular, interstitial and
airspace disease), pleural or ascetic exudates, pericardial
effusion, mediastinal or intra-abdominal lymph nodes, or
hypoechoic splenic lesions. Unfortunately, other infections and
malignancies can present in a similar manner.
Mycobacterial blood culture is highly desirable if resources
permit7 (for example using the Bactec Myco/F Lytic bottle), as
the technique has the potential to isolate bacteria, fungi and
Nocardia as well as Mycobacterium tuberculosis and M. avium
complex. However, the yield from urine culture in the context
of advanced HIV can be as good as mycobacterial blood
culture, and is less expensive.6 If a blood or urine culture is
requested the laboratory should be asked to use standard
tuberculosis culture techniques for up to 6 weeks and to
discuss all positive cultures with the clinician as
‘contaminants’ may be significant. The cryptococcal latex
agglutination test performed on serum or cerebrospinal fluid
rapidly confirms the diagnosis of Cryptococcus neoformans
infection. Bone marrow biopsy is appropriate if a full blood
count reveals bicytopenia or pancytopenia8 and liver biopsy is
appropriate if the cannalicular enzymes (ALP and GGT) are
elevated. Biopsy of enlarged peripheral lymph nodes using
either fine-needle aspiration or needle core can be helpful.9
Biopsy specimens should be divided equally between normal
saline for culture and formalin for histology.
It may be necessary to commence antituberculosis therapy
without a definitive diagnosis being made. If this route is
chosen a focal disease process compatible with tuberculosis
must have been clearly identified and every effort should be
made to send mycobacterial cultures before commencing
therapy. Should the patient not show an objective response to
therapy by 8 weeks an alternative diagnosis should be sought.6
The case study illustrates the propensity of ART-induced
immune reconstitution to provoke diseases mediated by viral
infections. Shingles (varicella zoster virus), condyloma
accuminata (human papillomavirus), hepatitis due to the
hepatitis B virus, and Kaposi’s sarcoma (human herpes virus 8)
can flare up in the months following successful initiation of
ART.10-12 In HIV-infected patients non-Hodgkin’s lymphoma is
closely associated with the Epstein-Barr virus and diagnosis
shortly after ART has been initiated has been described.13
Lymphoma-related B symptoms may have contributed to the
patient's weight loss and fever. The management of HIV-
associated malignancies differs from that of opportunistic
infections as ART should be initiated as soon as the diagnosis
is made in order to allow significant immune recovery before
chemotherapy is started. 
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